Trump Touts Choice, Cuts Medicaid Home Care Access
Trump promotes consumer choice in health care but limits access to popular Medicaid home care https://t.co/VxNeURdmwO #medicaid #olderadults #hcbs #seniors
Erika Schwartz Nominated to Lead CDC After Vacancy
#CDC has been without a director for most of Trump 2.0. A new nominee was put forward today, Erika Schwartz, a former deputy surgeon general. (Nomination was scooped earlier this week by @ddiamond & @bylenasun ). Let's see what happens....
Psychologist Argues Against Legalizing Psychedelics for Therapy
I'm not a narc. But as a psychologist and past clinical researcher, I currently oppose the legalization of psychedelics for mental health. Here's why.
Even Small Alcohol Increases Heart Rate, Lowers HRV
"Researchers looked at over 5 million days of data and found that even a modest amount of alcohol caused resting heart rates to climb and heart rate variability (a sign of how well your body handles stress) to drop." https://t.co/qg4663hHCS
Inside Epic's Confidential Vendor Deal Reveals Innovation Barriers
Second Opinion just published its first scoop: And it's a look inside Epic's confidential vendor services agreement. A source shared it with @RuthReader to give us a sense of why it's so hard out there for healthcare innovators. View in...
RFK Jr. Defends FDA Chief Amid Industry Backlash
RFK Jr. defends FDA, Makary following Republican questions - also defends the $REPL CRL: "Marty made the correct decision to not approve that drug. But everybody goes after him because the industry is so powerful." https://t.co/CuEeNFCYpp
OpenAI Debuts GPT‑Rosalind, Entering Biopharma After Anthropic
NEW: OpenAI is the latest tech giant to move into biopharma, launching Thursday GPT-Rosalind, a life sciences-tailored version of its LLM Trails behind the very similar launch of Anthropic's Claude for Life Sciences by ~5 months. More here: https://t.co/zkXDwY0BBI
Flawed Study Groups Failed and Successful Alzheimer Drugs Together
This new analysis of Alzheimer's drugs is such a good example of why we can't make any headway as a society. There is probably a good debate to be had on whether the risks and costs of the two approved beta...
RFK Jr. Hearing Reveals Changing Health Care Politics
RFK Jr.'s first in a marathon series of hearings offers a window into a shifting politics of health care — for the Trump administration and Democrats alike w/ @ChelseaCirruzzo https://t.co/uZQqM1ximT
High‑Resolution TORC2 Structure Opens Path to Age‑Related Therapies
Activating TORC2 holds potential in medicine for treating age-related memory & hearing loss. New study out today @MolecularCell reveals the structure of TORC2 in highest-ever resolution - which is good news for drug developers & all of us who age...
Drug Discovery Expands Beyond AI to New Frontiers
The marked expansion of paths and methods for new drug development including and beyond AI @Joseph_C_Wu @james_y_zou @WuXuekun @ScienceMagazine https://t.co/hTJ4Rt181n https://t.co/H3U5BNR1ER
Prediction Markets Threaten Public Health, Says Science Magazine
Prediction markets like @Polymarket are a threat for public health, asserted in a @ScienceMagazine essay https://t.co/Kk2OOVrxHy https://t.co/1pGA9aiBAh
Hygiene Breakthroughs Face Ridicule Before Saving Lives
Soap & disinfectants have saved more lives than any therapy Mother deaths before Semmelweis: ~10–15% After Semmelweis (1847):~1–2% Doctors laughed at him. He went to asylum & died from a beating Breakthroughs are ridiculed until they become part of everyday life
Best Cities for Top-Quality Eye Care
Do anyone tell me …. Which city would be best for eye treatment …. In terms if hospitals /doctors ….
1q22 Gain Predicts Poor Prognosis in Myeloma
Prognostic significance of acquired 1q22 gain in multiple myeloma [Oct 28, 2021] Hadiyah Y Audil et al. @myelomaMD Am J Hematol https://t.co/qUKCUdnZPH #mmsm #PrecisionMedicine #oncopath HT @EagleMyeloma https://t.co/vd0BVZ6bRq
1q Abnormalities Define Distinct Proteomic Landscape in Myeloma
Proteomic profiling revealed unique disease biology associated with 1q abnormalities in multiple myeloma [Apr 14, 2026] Mangalaparthi et al. @Nature_NPJ https://t.co/XTcJZIGFh6 #mmsm #PrecisionMedicine HT @Myeloma_Doc https://t.co/XyrxJ29elO
NHS Digital Skills Transfer Globally Across Health Systems
Your NHS digital skills are more portable than you think. Delivery, data and governance capabilities recur across health systems globally. Titles vary. Underlying capability travels. The global perspective is covered in Career Navigator 2026. Full Report: https://zurl.co/7tnFK
US Healthcare Overcharges: $2,000 Procedure vs $50 Abroad
Healthcare in the USA is such a scam. I had a gastric fibroscopy with a biopsy in Uruguay this week. I have private insurance and am not on the free healthcare here. I paid less than 50 USD. In the...
From Static Snapshots to Dynamic Protein Modeling
AlphaFold solved protein structure prediction. That's a snapshot. But biology isn't static. Proteins flex, shift, and interact across time. Drug targets have multiple conformations. Cells don't act alone. The next hard problem is capturing that motion, and building models that reflect...
Scientists Propose Abandoning GLP‑1 as Obesity Target
Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target https://t.co/ADzYb2Zqal via @statnews
US Study Links Telomere Length to Genes, Traits, Geography
Genomic, phenomic and geographic associations of leukocyte telomere length in the United States [Mar 27, 2026] @NakaoTetsushi et al. @NatureGenet https://t.co/3b75zEElAP https://t.co/jWNwYRWkQv
ATAI Fully Acquires Ibogaine Program, Champions Psychedelic Shift
I am a strong believer in ibogaine, which is one of the reasons why @ataibeckley acquired the residual interest in its ibogaine program in Q4 2023 and now owns it 100%. I’m very encouraged to see the administration taking a positive...
FDA Pushes New
First autism, now low T - FDA continues to do its own literature searches and encourage sponsors to apply for new indications (never saw this in prior admins — with the exception of updating old cancer drug labels to include...
AI Becomes Essential; Non‑Adopters Lose Doctors
Very soon, in radiology and medical centers using AI, you will hear: “Do you remember when we didn’t have it ? How did we manage ?” Institutions without AI won’t just lag, they’ll struggle to attract and retain physicians.
One in Three Men Suffer Pain, yet No Treatments
"If there was a condition that caused painful sex for one in three men for a year, we would have 12 different treatments by now."
Replimune Downsizes While MeiraGTx Regains Eye Therapy
Replimune cuts staff; MeiraGTx reacquires eye gene therapy https://t.co/LqGPyNzRA3 $REPL $MGTX $JNJ $BIIB $RVMD $APLS
Third‑generation T‑cell Engagers Advance Cancer Immunotherapy
Cancer immunotherapy keeps revving up. Now onto a 3rd generation of T cell engagers https://t.co/h05f8h3i8L https://t.co/PP5XE8WWDr
Liver Disease Emerges as Fourth Major T2D Complication in India
A recent study published in The Lancet Regional Health Southeast Asia highlights liver disease as the “fourth major complication” of Type 2 Diabetes (T2D) in India. https://t.co/BQPqgDInhe #research #diabetes #healthcare #india
Human Enhancement Is a Fundamental Right, Not Luxury
The United States Declaration of Independence enshrines the idea that every individual has the fundamental right to pursue a fulfilling and meaningful life. The government’s role is to protect that freedom - not to define happiness itself. I believe that one...
New Drug Extends Rheumatoid Arthritis Remission Years Post‑Treatment
Breakthrough Drug Delays Rheumatoid Arthritis for Years After Treatment Ends. https://t.co/03MjFzkPTM #research #RheumatoidArthritis #Arthritis #Pharma #healthcare
Women Should Ditch Bras and Prioritize Heart Health
Turns out women want to live.........Take off your bras ladies and get your hearts examined.
Medical Schools Finally Embrace Menopause and Heart Health
Recently I was invited to speak at the University of Vermont Medical School on Menopause and Women's Heart Health. I had to hold my breath. Can this be happening, I thought? Medical schools now want to hear about this? And...
Eltrombopag Proves More Cost-Effective than IVIG Perioperatively
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia [Jan 31, 2022] @ThisIsManraj et al. @BloodJournal https://t.co/2hr1CFmUro #ITP https://t.co/Fz6ZRjJHlk
CM313 Shows Promise as New ITP Therapy
A Novel Anti-CD38 Monoclonal Antibody [CM313] for Treating Immune Thrombocytopenia [Jun 19, 2024] Chen et al. @NEJM https://t.co/o9wf1ogUi4 #NCT05694767 #ITP https://t.co/aSXzpOHOtF
Fostamatinib Shows 79% Response, 54% Complete Remission in ITP
Fostamatinib [Syk inhib] effectiveness and safety for immune thrombocytopenia in clinical practice [August 8, 2024] @tomasjosegonza2 et al. @BloodPortfolio https://t.co/wrctRVBZsJ #ITP 79% RR, 53.6% CR https://t.co/OJfMY0DMah
Rilzabrutinib Shows Safety and Efficacy in Chronic ITP
Safety and efficacy of rilzabrutinib vs placebo in adults with [persistent/chronic] immune thrombocytopenia: the phase 3 LUNA3 study [Jun 12, 2025] Kuter et al. @BloodPortfolio https://t.co/hhnzXg3bqu #NCT04562766 #ITP https://t.co/IkjLnu1kTd
Elevated Lipoprotein(a Drastically Raises 30‑Year CVD Risk
Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a) 👉"Multivariable adjusted hazard ratios for levels above 120 mg/dL vs below 10 mg/dL or above the 99th percentile vs below the 50th percentile (11 mg/dL) were 1.54...
Daratumumab Shows Safety and Efficacy in ITP
Safety and Efficacy of Daratumumab in Immune Thrombocytopenia (#ITP) [Aug 5, 2025] Tsykunova et al. @BloodPortfolio https://t.co/GHyJGG7YSe #NCT04703621 https://t.co/pBgjzTCGQl
Ianalumab Combined with Eltromb
Ianalumab [VAY736] plus Eltrombopag in Immune Thrombocytopenia [Dec 9, 2025] @CukerMd et al. for the VAYHIT2 Investigators @NEJM https://t.co/99urXh8agT #NCT05653219 #ITP https://t.co/qKKhwv4ofR
Duchenne Kids Show Dramatic Improvement After Microdystrophin Treatment
A couple of weeks ago when I visited Solid Bio, they showed me some videos of Duchenne kids pre and post microdystrophin treatment that I was amazed by - but they weren't sharable yet. Bo just presented them at Needham...
Two ePA Routes for Same Drug Create Workflow Chaos
A rheumatologist prescribes Humira for a patient with Crohn's. The patient might self-inject at home with a prefilled pen or come into the infusion center for IV administration. Same drug, doctor and patient, so must be straightforward, right? Under CMS-0062, two...
Prophylactic IOPIDINE Cuts Post‑Surgery IOP Spikes 91%
$HROW A J-code makes Medicare reimbursement routine. "indicated to control or prevent post-surgical elevations in IOP that occur in patients after argon laser trabeculoplasty, argon laser iridotomy or Nd:YAG posterior capsulotomy" "Prophylactic use of IOPIDINE 1% has been shown to reduce severe...
Anti‑amyloid Drugs Show Trivial, Non‑meaningful Cognitive Benefit
The effect of current anti-amyloid drugs vs Alzheimer's disease is "trivial" for cognitive function or dementia severity, not clinically meaningful, from a systematic @cochranecollab review of 17 trials, >20,000 patients https://t.co/9A6PeZOyAt https://t.co/c1PCOYZxws
FDA Approves Kidney Drug Despite No Functional Benefit
This week's Biotech Scorecard newsletter: $TVTX Travere Therapeutics' drug for a rare kidney disease doesn’t improve kidney function. The FDA approved it anyway. https://t.co/63hDsPfOcT
Digital Tech Will Revolutionize Healthcare: 20 Future Trends
Digital technology could help transform unsustainable healthcare systems, provide cheaper, faster, and more effective solutions for diseases – and could lead to healthier individuals living in healthier communities. In this book, we analyze the top 20 trends shaping the future of...
GLP‑1 Drugs Don’t Disproportionately Reduce Functional Muscle, DXA Misleads
1/2) New research suggests GLP-1 weight loss drugs probably do NOT cause disproportionate loss of functional lean muscle. The confusion has arisen from the fact that DXA scans capture and pool a lot of different organs and tissues into the category...
Roche Initiates New Elevidys Trial Targeting EU Approval
Roche to launch another Elevidys trial, with eyes on European approval https://t.co/eAANNiihpt via @DrewQJoseph $SRPT
Ozempic's “Personality” Fuels Pervasive Life‑level Ennui
The ennui molecule. What is ‘Ozempic personality,’ and why does it make life feel ‘meh’? https://t.co/toW9XopfGA
Ozempic Face Exists, Not Caused by the Medication
“Ozempic face” is real… but bukan sebab ubat tu rosakkan muka you. Let’s clear this properly 👇
EPA Rolls Back Regulation on Carcinogenic Sterilization Gas
A carcinogenic gas is used to sterilize medical equipment. After communities near these facilities fought for tougher regulation, Trump's EPA is rolling it back https://t.co/GimpbVCeEt